Provided by Tiger Fintech (Singapore) Pte. Ltd.

Journey Medical Corp

6.88
-0.0700-1.01%
Volume:41.89K
Turnover:289.68K
Market Cap:158.96M
PE:-9.58
High:7.15
Open:6.93
Low:6.80
Close:6.95
Loading ...

Strength Seen in Profound Medical (PROF): Can Its 8.3% Jump Turn into More Strength?

Zacks
·
05 May

Why Journey Medical Corporation (DERM) is Surging in 2025

Insider Monkey
·
30 Apr

Journey Medical (DERM) Moves 16.8% Higher: Will This Strength Last?

Zacks
·
23 Apr

Is Journey Medical Corporation (DERM) a Cheap Hot Stock to Buy Right Now?

Insider Monkey
·
19 Apr

Journey Medical (DERM) Surges 9.1%: Is This an Indication of Further Gains?

Zacks
·
07 Apr

Journey Medical Corp Appoints New Chief Operating Officer

TIPRANKS
·
03 Apr

Journey Medical Promotes Ramsey Alloush to COO

MT Newswires Live
·
02 Apr

Journey Medical Names Alloush COO

Dow Jones
·
02 Apr

Journey Medical Corporation Appoints Ramsey Alloush as Chief Operating Officer

GlobeNewswire
·
02 Apr

Journey Medical Full Year 2024 Earnings: EPS Beats Expectations, Revenues Lag

Simply Wall St.
·
28 Mar

Q4 2024 Journey Medical Corp Earnings Call

Thomson Reuters StreetEvents
·
27 Mar

Journey Medical Corp (DERM) Q4 2024 Earnings Call Highlights: Strategic Launch of Emrosi and ...

GuruFocus.com
·
27 Mar

Journey Medical Corp reports results for the quarter ended December 31 - Earnings Summary

Reuters
·
27 Mar

Journey Medical reports FY24 EPS (72c) vs (21c) last year

TIPRANKS
·
27 Mar

Press Release: Journey Medical Corporation Reports Full-Year 2024 Financial Results and Recent Corporate Highlights

Dow Jones
·
27 Mar

Journey Medical launches Emrosi for the treatment of rosacea

TipRanks
·
25 Mar

Journey Medical Corp expected to post a loss of 35 cents a share - Earnings Preview

Reuters
·
25 Mar

Journey Medical Corporation Launches Emrosi™ (40 Mg Minocycline Hydrochloride Modified-Release Capsules, 10 Mg Immediate Release and 30 Mg Extended Release) for the Treatment of Rosacea

THOMSON REUTERS
·
24 Mar

Journey Medical Corporation Launches Emrosi™ (40 mg Minocycline Hydrochloride Modified-Release Capsules, 10 mg immediate release and 30 mg extended release) for the Treatment of Rosacea

GlobeNewswire
·
24 Mar

Calendar of U.S. Earnings Expected in the Week Ahead

Dow Jones
·
24 Mar